High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy. However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to treat Crohn’s disease (CD), on vaccination response. In this prospective study, we assessed immune responses to se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: Doornekamp, Laura, Goetgebuer, Rogier L., Schmitz, Katharina S., Goeijenbier, Marco, van der Woude, C. Janneke, Fouchier, Ron, van Gorp, Eric C.M., de Vries, Annemarie C.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565576/
https://ncbi.nlm.nih.gov/pubmed/32824111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030455
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados